GMED
Globus Medical
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: GMED
- PE Ratio
The price-to-earnings ratio for Globus Medical stock stands at 18.2 as of Jun 22, 2026. This is calculated based on the current EPS of $4.35 and the stock price of $79.19 per share. A decrease of 12% has been recorded in the PE ratio compared to the average of 20.6 of the past four quarters.
GMED PE ratio history
Over the last ten years, the average PE ratio of Globus Medical has been 46.57. The current 18.2 price-to-earnings ratio is 61% less than the historical average. In the past ten years, GMED's PE ratio reached its highest point in the Jun 2024 quarter at 273.96, with a price of $68.49 and an EPS of $0.25. The Sep 2025 quarter saw the lowest point at 18.3, with a price of $57.27 and an EPS of $3.13.
Globus Medical PE ratio by year
Maximum annual increase: 122.6% in 2024
Maximum annual decrease: -79.84% in 2025
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 21.94 | -79.84% | $87.31 | $3.98 |
| 2024 | 108.83 | 122.6% | $82.71 | $0.76 |
| 2023 | 48.89 | 24.4% | $53.29 | $1.09 |
| 2022 | 39.3 | -19.43% | $74.27 | $1.89 |
| 2021 | 48.78 | -22.21% | $72.2 | $1.48 |
| 2020 | 62.71 | 67.23% | $65.22 | $1.04 |
| 2019 | 37.5 | 38.63% | $58.88 | $1.57 |
| 2018 | 27.05 | -26.29% | $43.28 | $1.6 |
| 2017 | 36.7 | 61.25% | $41.1 | $1.12 |
| 2016 | 22.76 | -2.65% | $24.81 | $1.09 |
| 2015 | 23.38 | -3.63% | $27.82 | $1.19 |
| 2014 | 24.26 | -11.04% | $23.77 | $0.98 |
| 2013 | 27.27 | 113.21% | $20.18 | $0.74 |
| 2012 | 12.79 | N/A | $10.49 | $0.82 |
| 2011 | N/A | N/A | N/A | $0.69 |
Globus Medical PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 19.81 | -9.71% | $86.16 | $4.35 |
| Dec 2025 | 21.94 | 19.89% | $87.31 | $3.98 |
| Sep 2025 | 18.3 | -18.45% | $57.27 | $3.13 |
| Jun 2025 | 22.44 | -58.31% | $59.02 | $2.63 |
| Mar 2025 | 53.82 | -50.55% | $73.2 | $1.36 |
| Dec 2024 | 108.83 | -5.69% | $82.71 | $0.76 |
| Sep 2024 | 115.39 | -57.88% | $71.54 | $0.62 |
| Jun 2024 | 273.96 | 201.32% | $68.49 | $0.25 |
| Mar 2024 | 90.92 | 85.97% | $53.64 | $0.59 |
| Dec 2023 | 48.89 | 54.62% | $53.29 | $1.09 |
| Sep 2023 | 31.62 | 8.32% | $49.65 | $1.57 |
| Jun 2023 | 29.19 | 3.58% | $59.54 | $2.04 |
| Mar 2023 | 28.18 | -28.3% | $56.64 | $2.01 |
| Dec 2022 | 39.3 | 1.6% | $74.27 | $1.89 |
| Sep 2022 | 38.68 | 5.42% | $59.57 | $1.54 |
GMED Price vs fair value
GMED average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of GMED is lower than the 3, 5 and 10-year averages.
PE comparison
With a P/E of 18.2, GMED stands below the Healthcare sector and the industry average. Looking at its Healthcare sector average of 24.1, Globus Medical's P/E is 24% lower.
GMED PE vs peers
GMED's PE ratio is below its peer stock SYK.
| Stock name | PE ratio | Market cap |
|---|---|---|
| GMED Globus Medical Inc | 18.35 | $10.84B |
| SYK Stryker Corp | 35.34 | $118.41B |
| OFIX Orthofix Medical Inc | N/A | $370.26M |
| ATEC Alphatec Holdings Inc | N/A | $1.32B |
Frequently asked questions
What is Globus Medical's PE ratio?
The price to earnings ratio for GMED stock as of Jun 22, 2026, stands at 18.2.
What is the 3-year average PE ratio for Globus Medical (GMED)?
Over the last 3 years, the average PE ratio for GMED stock is 69.59.
What is the 5-year average PE ratio for Globus Medical (GMED)?
Over the last 5 years, the average PE ratio for GMED stock is 58.12.
What is the highest PE ratio for GMED?
In the last ten years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 273.96.
How does the current PE ratio for GMED compare to its historical average?
The current price to earnings ratio of GMED is 61% lower than the 10-year historical average.
How is GMED's PE ratio calculated (Globus Medical PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 22, 2026), Globus Medical's stock price is $79.19. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $4.35. Therefore, Globus Medical's price to earnings ratio for today is 18.2. PE RATIO(18.2) = STOCK PRICE($79.19) / TTM EPS($4.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.